Your wallet likely holds a credit card that offers more than just credit. Perks like purchase protection, travel insurance, or payment waivers in case of job loss are common. While customers see these as valuable benefits, for finance executives, they present a critical accounting question under IFRS 17: Is this credit card also an insurance contract?
The answer determines whether you need to apply the complex IFRS 17 accounting model. The standard is clear: if a contract transfers significant insurance risk, it falls within its scope. For credit cards, the challenge is separating the core lending function from potential insurance elements and then measuring the significance of that insurance risk.
What is 'Significant Insurance Risk'?
IFRS 17 doesn't define 'significant' with a hard number. Instead, it provides a principle-based test. Insurance risk is significant if an insured event could cause the issuer (the bank or lender) to pay significant additional amounts in at least one plausible scenario.
The key is to compare the net cash flows for the issuer in two different worlds: one where the insured event happens, and one where it doesn’t. If the difference in the payout from the issuer's perspective is significant, you have an insurance component to account for.
Putting the Significance Test into Practice
Let's consider a common feature: a payment protection plan that waives the cardholder's outstanding balance upon involuntary job loss. Imagine a customer with a $15,000 balance.
Scenario 1: No insured event. The customer keeps their job and continues to make payments. Over time, the bank expects to receive the $15,000 principal plus interest.
Scenario 2: Insured event occurs. The customer loses their job, triggering the protection clause. The bank is contractually obligated to waive the entire $15,000 balance. It receives nothing further.
In this case, the 'additional amount' the bank effectively 'pays' (by forgoing receivables) is $15,000. This loss, triggered by an uncertain future event (job loss), is almost certainly significant to the economics of that individual contract. Therefore, this credit card contains a significant insurance component.
Contrast this with a feature like a small waiver of a late fee in certain circumstances. The 'additional amount' might only be $35. This is unlikely to be considered significant, and the contract would probably remain outside the scope of IFRS 17.
Why This Assessment Matters
Identifying a significant insurance component is not just an academic exercise. If a component is deemed significant, IFRS 17 may require you to 'unbundle' it—separating the insurance element from the lending element—and account for it under the new insurance standard. This introduces significant complexity into data, systems, and valuation processes.
The first step for any credit card issuer is a thorough review of its product portfolio. By systematically applying the 'significant additional amounts' test to each feature, you can build a clear and defensible position on which contracts fall within the scope of IFRS 17 and avoid any unwelcome surprises.
Need Help With Your IFRS 17 Valuation?
Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 17 valuations.
Get a Quote